TSG101 and breast cancer: Similar to breast cancer, it has been reported that TSG101 is upregulated in human ovarian epithelial cells that express oncogenic HRAS or KRAS as well as in 70% of human ovarian carcinomas analyzed on tissue arrays [63,72,74].